OKYO Stock Analysis: Buy, Sell, or Hold?
OKYO - OKYO Pharma Limited Ordinary Shares
$2.05
0.01 (0.49%)
▲
HOLD
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
24d
Get Alerted When OKYO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called OKYO this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OKYO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: OKYO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: OKYO is currently trading at $2.05, which is considered fair relative to its 30-day fair value range of $1.97 to $2.58.
Technical Outlook: Technically, OKYO is showing sideways momentum. Immediate support is located at $1.93, while resistance sits at $2.53.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+390.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OKYO is showing sideways momentum. Immediate support is located at $1.93, while resistance sits at $2.53.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+390.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.97 -
$2.58
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
Protect Your Profits
Holding OKYO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 390.2% below Wall St target ($10.00)
- CAUTION: Recommendation downgraded due to -7.7% 5-day decline
Fair Price Analysis
30-Day Fair Range
$1.97 -
$2.58
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.93
Resistance Level
$2.53
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-7.29
Wall Street Target
$10.00
(+390.2%)
Last updated: January 31, 2026 6:02 AM ET
Data refreshes hourly during market hours. Next update: 7:02 AM
Data refreshes hourly during market hours. Next update: 7:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OKYO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$89 | 61 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
Advanced OKYO Option Strategies
Professional options setups generated by AI based on today's OKYO price and gamma walls.